Macimorelin

Macimorelin contains a peptide-influenced scaffold enabling analysis of receptor-binding determinants and structural flexibility. Hydrophobic and polar functionalities support stable solution behavior. Researchers evaluate its conformational preferences for structural modeling. Applications include ligand screening, peptide analog research, and interaction analysis.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Macimorelin(CAS 381231-18-1)

CAT No: R2717

CAS No:381231-18-1

Synonyms/Alias:Macimorelin;381231-18-1;AEZS-130;ARD-07;EP-1572;JMV-1843;EP1572;JMV 1843;macimorelina;macimoreline;Macimorelin [USAN:INN];UNII-8680B21W73;EP 1572;EP-01572;Aib-DTrp-DgTrp-CHO;ARD 07;JMV1843;ARD07;AEZS130;CHEMBL278623;8680B21W73;UMV1843;D-87575;381231-18-1 (free base);Macimorelin (USAN);2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide;MACIMORELIN [USAN];Aminoisobutyryl-tryptophyl-tryptophanamine-formyl;Solorel;2-amino-N-((R)-1-(((R)-1-formamido-2-(1H-indol-3-yl)ethyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-2-methylpropanamide;N(SUP 2)-(2-AMINO-2-METHYLPROPANOYL-N1-((1R)-1-FORMAMIDO-2-(1H-INDOL-3-YL)ETHYL)-D-TRYPTOPHANAMIDE;Macimorelin [INN];macimorelinum;EP 1572; JMV 1843; Macimorelin;MACIMORELIN [MI];MACIMORELIN [WHO-DD];GTPL9745;SCHEMBL1984708;V04CD06;DTXSID601045766;GLXC-25240;BDBM50125886;DB13074;EP01572;HY-14820;CS-0003577;NS00068665;D10563;EN300-24449845;Q15624037;D-Tryptophanamide,2-methylalanyl-N-((1R)-1-(formylamino)-2-(1H-indol-3-yl)ethyl)-;(2R)-2-(2-amino-2-methylpropanamido)-3-(1H-indol-3-yl)-N-[(1R)-2-(1H-indol-3-yl)-1-formamidoethyl]propanamide;2-Amino-N-{(R)-1-[(R)-1-formylamino-2-(1H-indol-3-yl)-ethylcarbamoyl]-2-1H-indol-3-yl-ethyl}-2-methyl-propionamide;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C26H30N6O3
M.W/Mr.
474.6
Sequence
One Letter Code:XW
InChI
InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1
InChI Key
UJVDJAPJQWZRFR-DHIUTWEWSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide CDMOPeptide Synthesis ServicescGMP Peptide ServicePeptide Modification ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesisEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers